Carol, MD, a distinguished innovator in the areas of intensity modulated radiation therapy and image-guided radiation therapy , as its 2012 Honorary Member, which may be the highest honor the Culture bestows upon distinguished malignancy researchers and leaders in disciplines other than radiation oncology, radiation radiobiology or physics. Carol will be regarded with this honor through the Awards Ceremony on Tuesday, 30 October, 2012, at 10:45 a.m., at ASTRO’s 54th Annual Meeting, October 28-31, 2012, at the Boston Convention and Exhibition Center. Related StoriesStudy shows uncommon HER2 missense mutations usually do not spread breast cancer on their ownNew antenna-like gadget makes breast cancer surgery easier for surgeonsSausages With Antioxidants From Berries TO AVOID CancerWith more than 30 years of experience in the medical device and healthcare services arenas, Carol can be often considered the father of IMRT.People working in agriculture had been among those with the lowest risk, the researchers mentioned in a journal information release. Gender also were key, with risks for the condition rising faster among females than men, the scholarly study showed. According to Catto’s group, this might simply be the result of improvements in screening and detection of the condition – – more situations being detected. However, higher numbers in women may also be the total consequence of rising numbers of women in the workforce, or an increasing number of carcinogens in jobs held by females predominantly, the study authors said. Efforts to reduce the chance of bladder cancers among workers should target jobs associated with the greatest risk of death from the disease, the researchers said.